F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea
Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep disorder.
More than 60 million Americans battle insomnia, and counting sheep, reading dull books or skipping naps isn't helping. Here ...
T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by ...
A sleep study can show how severe sleep apnea is and help determine the best course of treatment. People can discuss the potential benefits and risks of a mouthguard with their doctor. If they ...
“They also have increased prevalence of sleep apnea, hence evaluating markers of brain health such as the one mentioned serve as a way to understand early markers of disease risk for Alzheimer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback